288 related articles for article (PubMed ID: 8980628)
21. [Aminoglycoside resistance of Acinetobacter baumannii hospital strains in the Czech Republic].
Nemec A; Maixnerová M
Klin Mikrobiol Infekc Lek; 2004 Oct; 10(5):223-8. PubMed ID: 15558451
[TBL] [Abstract][Full Text] [Related]
22. Resistance to gentamicin and amikacin of gram-negative organisms isolated from horses.
Orsini JA; Benson CE; Spencer PA; Van Miller E
Am J Vet Res; 1989 Jun; 50(6):923-5. PubMed ID: 2669575
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and mechanisms of aminoglycoside resistance. A ten-year study.
Phillips I; King A; Shannon K
Am J Med; 1986 Jun; 80(6B):48-55. PubMed ID: 3728534
[TBL] [Abstract][Full Text] [Related]
24. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
Xiao Y; Hu Y
Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
[TBL] [Abstract][Full Text] [Related]
25. [Enzymatic mechanisms of resistance to aminoglycoside antibiotics in gram negative bacilli from Chilean hospitals].
Del Solar E; García A; Bello H; Domínguez M; González G; Zemelman R
Rev Med Chil; 1995 Mar; 123(3):293-7. PubMed ID: 8525167
[TBL] [Abstract][Full Text] [Related]
26. [Current status of aminoglycoside resistance in hospital Enterobacteriaceae].
Ronco E; Migueres ML; Vacheron F; Guenounou M
Pathol Biol (Paris); 1988 May; 36(5):430-4. PubMed ID: 3043339
[TBL] [Abstract][Full Text] [Related]
27. Appearance of aac(6')-Ib-cr gene among extended-spectrum beta-lactamase-producing Enterobacteriaceae in a French hospital.
Fihman V; Lartigue MF; Jacquier H; Meunier F; Schnepf N; Raskine L; Riahi J; Sanson-le Pors MJ; Berçot B
J Infect; 2008 Jun; 56(6):454-9. PubMed ID: 18440645
[TBL] [Abstract][Full Text] [Related]
28. [Resistance of blood culture isolates in vitro to 4 aminoglycoside antibiotics in Austria--1982/83].
Mittermayer H; Rotter M; Thiel W; Breitfellner G
Wien Klin Wochenschr; 1985 Mar; 97(7):334-9. PubMed ID: 3993043
[TBL] [Abstract][Full Text] [Related]
29. Isepamicin (SCH 21420, 1-N-HAPA gentamicin B): microbiological characteristics including antimicrobial potency of spectrum of activity.
Jones RN
J Chemother; 1995 Jun; 7 Suppl 2():7-16. PubMed ID: 8622113
[TBL] [Abstract][Full Text] [Related]
30. [Susceptibility of gram-negative bacilli to aminoglycosides].
Willke A; Tural D
Mikrobiyol Bul; 1987 Apr; 21(2):98-102. PubMed ID: 3328818
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
Braveny I; Voeckl J; Machka K
Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
[TBL] [Abstract][Full Text] [Related]
32. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
[No Abstract] [Full Text] [Related]
33. Dissemination of Genes Encoding Aminoglycoside-Modifying Enzymes and armA Among Enterobacteriaceae Isolates in Northwest Iran.
Ghotaslou R; Yeganeh Sefidan F; Akhi MT; Asgharzadeh M; Mohammadzadeh Asl Y
Microb Drug Resist; 2017 Oct; 23(7):826-832. PubMed ID: 28151044
[TBL] [Abstract][Full Text] [Related]
34. [In vitro study of the synergistic effect of cefmenoxime-aminoglycoside combinations apropos of 148 strains of Enterobacteriaceae].
Husson MO; Izard D; Bryskier A; Leclerc H
Pathol Biol (Paris); 1984 May; 32(5):396-8. PubMed ID: 6330651
[TBL] [Abstract][Full Text] [Related]
35. Aminoglycoside resistance patterns in clinical isolates of E. coli and Klebsiella sp. from Czechoslovakia and the United States.
Navarová J; Kettner K; Krcméry V; Folrichová D
J Hyg Epidemiol Microbiol Immunol; 1989; 33(4):477-86. PubMed ID: 2696761
[TBL] [Abstract][Full Text] [Related]
36. Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals.
Cho YJ; Moon DC; Jin JS; Choi CH; Lee YC; Lee JC
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):185-90. PubMed ID: 19361944
[TBL] [Abstract][Full Text] [Related]
37. Characterization of aminoglycoside-modifying enzymes in enterobacteriaceae clinical strains and characterization of the plasmids implicated in their diffusion.
Miró E; Grünbaum F; Gómez L; Rivera A; Mirelis B; Coll P; Navarro F
Microb Drug Resist; 2013 Apr; 19(2):94-9. PubMed ID: 23206280
[TBL] [Abstract][Full Text] [Related]
38. Enzymatic modification of aminoglycoside antibiotics in gentamicin-resistant gram-negative bacteria.
Kettner M; Navarová J; Lebek G; Krcméry V
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):372-82. PubMed ID: 6091367
[TBL] [Abstract][Full Text] [Related]
39. The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey.
Over U; Gür D; Unal S; Miller GH;
Clin Microbiol Infect; 2001 Sep; 7(9):470-8. PubMed ID: 11678929
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]